|
DGAP-News: SHOP APOTHEKE EUROPE N.V.
/ Key word(s): Miscellaneous
SHOP APOTHEKE EUROPE: Move to Next Generation Logistics Centre Completed. The new facility with an operating area of 40,000 square meters is designed to keep pace with SHOP APOTHEKE EUROPE's steadily growing order volume. Compared to the old site in Venlo, capacity was more than doubled while a higher degree of automation means processes can run more efficiently, enabling SHOP APOTHEKE EUROPE to process and ship over 100,000 parcels a day (old site: around 39,000 parcels) or more than 35 million parcels per year to its customers in currently seven Continental European markets. At the same time, the new building is also in alignment with the company's sustainability strategy focusing on the care of patients, employees, and the planet: It has been certified "excellent" for meeting the highest environmental standards as defined by BREEAM, the world's longest-established method for assessing, rating and certifying the sustainability of buildings. In addition, the solar panels on the rooftop will be able to provide 100% of all energy used at the site during the day. Energy for nighttime operations will be sourced from 100% renewable energies. Stefan Feltens, CEO of SHOP APOTHEKE EUROPE, comments: "Our new logistics centre ensures that we will be able to meet our ambitious growth targets and keep up with the anticipated increasing demand of the coming years, especially in light of the introduction of electronic prescriptions, which will become mandatory in Germany in 2022. We are very happy that we have completed our move since the simultaneous operation of two logistics sites had added complexity to our processes over the past weeks and months." ABOUT SHOP APOTHEKE EUROPE. Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Paris and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 7 million active customers trust SHOP APOTHEKE EUROPE. Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services. In preparation for the introduction of electronic prescriptions in Germany in summer 2021, the company will further improve the customer experience with focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer into a truly customer-centric e-pharmacy platform. SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.
Trade and popular media: Financial media: Investor relations: Thomas Schnorrenberg
16.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Dirk Hartogweg 14 | |
| 5928 LV Venlo | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | |
| Internet: | -apotheke-europe.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y07 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1234010 |
| End of News | DGAP News Service |
|
|
1234010 16.09.2021
